Lux Health Tech Acquisition (Lux Health Tech Acquisition) Change In Receivables : $0.00 Mil (TTM As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Lux Health Tech Acquisition Change In Receivables?

Lux Health Tech Acquisition's change in receivables for the quarter that ended in Jun. 2022 was $0.00 Mil. It means Lux Health Tech Acquisition's Accounts Receivable stayed the same from Mar. 2022 to Jun. 2022 .

Lux Health Tech Acquisition's change in receivables for the fiscal year that ended in Dec. 2021 was $0.00 Mil. It means Lux Health Tech Acquisition's Accounts Receivable stayed the same from Dec. 2020 to Dec. 2021 .

Lux Health Tech Acquisition's Accounts Receivable for the quarter that ended in Jun. 2022 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lux Health Tech Acquisition's liquidation value for the three months ended in Jun. 2022 was $-15.86 Mil.

Lux Health Tech Acquisition Change In Receivables Historical Data

The historical data trend for Lux Health Tech Acquisition's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lux Health Tech Acquisition Change In Receivables Chart

Lux Health Tech Acquisition Annual Data

Trend

Dec20

Dec21

Change In Receivables

Lux Health Tech Acquisition Quarterly Data
	Aug20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Lux Health Tech Acquisition Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Lux Health Tech Acquisition (NAS:LUXAU) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Lux Health Tech Acquisition's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Lux Health Tech Acquisition's accounts receivable are only considered to be worth 75% of book value:

Lux Health Tech Acquisition's liquidation value for the quarter that ended in Jun. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.025	-	15.888	+	0.75 * 0	+	0.5 * 0
=	-15.86

Lux Health Tech Acquisition Change In Receivables Related Terms

Thank you for viewing the detailed overview of Lux Health Tech Acquisition's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXAU) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

920 Broadway, 11th Floor, New York, NY, USA, 10010

Website

https://www.luxcapital.com

Lux Health Tech Acquisition Corp is a blank check company.

Executives

Frederic H Moll	director	C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Joshua Defonzo	director, officer: Chief Executive Officer	1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070
Peter Hebert	director, 10 percent owner	C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017
J Robert Kerrey	director	NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Josh Wolfe	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Bijan Salehizadeh	director	C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005
Segolene Scarborough	officer: CFO and Treasurer	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Sponsor, Lp	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Holdings, Llc	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines

From GuruFocus

Lux Health Tech Acquisition Corp. Announces Closing of $345 Million Initial Public Offering

By Business Wire Business Wire • 10-29-2020

Lux Health Tech Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 14, 2020

By Business Wire Business Wire • 12-11-2020